JNS.org – An Israeli pediatrician has launched a clinical trial to study the effects of medical cannabis on autistic children and adults, Haaretz reported.
Dr. Adi Eran, head of the pediatric neurology department at Shaare Zedek Medical Center in Jerusalem, is obtaining permits from Israel’s Ministry of Health to test 120 low-to-medium functioning autistic individuals, aged 4 to 30.
The participants will be given cannabis oils rich in cannabidiol (CBD), one of 113 active chemicals found in cannabis that makes up 40 percent of the plant’s extracts. The substance is non-hallucinogenic.
Read more
Dr. Adi Eran, head of the pediatric neurology department at Shaare Zedek Medical Center in Jerusalem, is obtaining permits from Israel’s Ministry of Health to test 120 low-to-medium functioning autistic individuals, aged 4 to 30.
The participants will be given cannabis oils rich in cannabidiol (CBD), one of 113 active chemicals found in cannabis that makes up 40 percent of the plant’s extracts. The substance is non-hallucinogenic.
Read more
